BAX Baxter International Inc.
Healthcare$19.18+0.79%ClosedMarket Cap: $9.91B
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
1.63
P/S
0.88
EV/EBITDA
23.62
DCF Value
$-3.08
FCF Yield
7.2%
Div Yield
1.9%
Margins & Returns
Gross Margin
30.1%
Operating Margin
-2.7%
Net Margin
-9.7%
ROE
-16.4%
ROA
-5.5%
ROIC
-1.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $2.70B | 33.0% | $66.0M | $-15.0M | $— | $0.01 |
| Q4 null | $2.97B | 19.4% | $-729.0M | $-1.13B | $— | $0.01 |
| FY null | $11.24B | 30.1% | $-308.0M | $-957.0M | $— | $0.52 |
| Q3 null | $2.83B | 33.5% | $172.0M | $-46.0M | $— | $0.17 |
| Q2 null | $2.81B | 35.3% | $191.0M | $91.0M | $— | $0.17 |
| Q1 null | $2.63B | 32.8% | $58.0M | $126.0M | $— | $0.17 |
| Q4 null | $2.75B | 34.8% | $-435.0M | $-512.0M | $— | $0.17 |
| FY null | $10.64B | 37.5% | $14.0M | $-649.0M | $— | $1.04 |
| Q3 null | $2.70B | 38.3% | $155.0M | $140.0M | $— | $0.29 |
| Q2 null | $2.69B | 38.3% | $179.0M | $-314.0M | $— | $0.29 |
| Q1 null | $2.49B | 38.6% | $115.0M | $37.0M | $— | $0.29 |
| Q4 2023 | $3.88B | 37.9% | $329.0M | $245.0M | $0.48 | $0.29 |